MedcomSoft to unveil a revolutionary new EMR product at HIMSS

TORONTO, Feb. 12 /PRNewswire-FirstCall/ -- MedcomSoft Inc. (TSX - MSF) today announced that it will unveil its new EMR product code-named (MP2C) at the "Healthcare Information and Management Systems Society" (HIMSS) conference and exhibition in Orlando on February 24th, 2004. MedcomSoft new product could potentially revolutionize the way "Secure", "Intelligent", "Complete" and "Detailed" clinical records can follow patients to virtually any point of care allowing providers, using a variety of different systems, to instantaneously aggregate and analyze any and all the patient data related to any of his conditions before the administration of further care. The adoption and use of this new product could very rapidly contribute to a dramatic decrease in medical errors, a decrease in redundant tests or duplication of procedures and a leapfrog towards the interoperability and portability of patient charts as described and mandated by the U.S. Administration "Health Insurance Portability and Accountability Act" (HIPAA).

Detailed information, presentations and press interviews will be provided at MedcomSoft exhibit in booth No. 5312 at HIMSS starting February 24th.

MedcomSoft Inc. designs, develops and markets cutting-edge software solutions to the healthcare industry. MedcomSoft has pioneered the use of codified point of care medical terminologies and intelligent pen-based data capture systems to create a new generation of electronic medical records (EMR). As a result of MedcomSoft innovations, physicians and managed care organizations can now securely build and exchange complete, structured and homogeneous electronic patient records. MedcomSoft applications are written with the latest Microsoft tools to run on the Windows platform (Windows 2000 & XP), operate with MS SQL Server 2000(TM), support MS Terminal Server and fully integrate with MS Office 2003, Exchange and Outlook(R). MedcomSoft applications are fully compatible with Tablet PCs and wireless technology.

This news release contains projections and other forward-looking statements regarding future events. Such statements are predictions, which involve known and unknown risks, uncertainties and other factors, which may cause the actual events or results to differ materially. The reader is referred to the documents that the company files from time to time with applicable Canadian securities and regulatory authorities.

MedcomSoft Inc.

CONTACT: Brett Quance, Director of Sales, MedcomSoft Inc., 1200 Eglinton
Avenue East, Suite 900, Toronto, Ontario M3C 1H9, Phone: (416) 443-8788 ext.
222, Fax: (416) 443-9693,
http://www.medcomsoft.com/, E-mail: ir@medcomsoft.com